BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 2473952)

  • 1. Suppression of frequently recurring genital herpes: acyclovir v inosine pranobex.
    Mindel A; Carney O; Sonnex C; Freris M; Patou G; Williams P
    Genitourin Med; 1989 Apr; 65(2):103-5. PubMed ID: 2473952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of first-attack genital herpes--acyclovir versus inosine pranobex.
    Mindel A; Kinghorn G; Allason-Jones E; Woolley P; Barton I; Faherty A; Jeavons M; Williams P; Patou G
    Lancet; 1987 May; 1(8543):1171-3. PubMed ID: 2437417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative studies of inosine pranobex and acyclovir.
    Mindel A
    Am J Med; 1988 Aug; 85(2A):7-9. PubMed ID: 2457315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicenter randomized study of inosine pranobex versus acyclovir in the treatment of recurrent herpes labialis and recurrent herpes genitalis in Chinese patients.
    You Y; Wang L; Li Y; Wang Q; Cao S; Tu Y; Li S; Bai L; Lu J; Wei Z; Chen W; Hao F
    J Dermatol; 2015 Jun; 42(6):596-601. PubMed ID: 25819042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acyclovir vs isoprinosine (immunovir) for suppression of recurrent genital herpes simplex infection.
    Kinghorn GR; Woolley PD; Thin RN; De Maubeuge J; Foidart JM; Engst R
    Genitourin Med; 1992 Oct; 68(5):312-6. PubMed ID: 1385295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term oral acyclovir treatment prevents recurrent genital herpes.
    Blom I; Bäck O; Egelrud T; Frödin T; Hellbe L; Johannisson G; Malmros-Enander I; Molin L
    Dermatologica; 1986; 173(5):220-3. PubMed ID: 3100353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inosiplex in recurrent herpes simplex infection.
    Abeles JH
    Lancet; 1982 Oct; 2(8304):926. PubMed ID: 6181365
    [No Abstract]   [Full Text] [Related]  

  • 8. Double-blind, placebo-controlled trial comparing long-term suppressive with short-term oral acyclovir therapy for management of recurrent genital herpes.
    Mattison HR; Reichman RC; Benedetti J; Bolgiano D; Davis LG; Bailey-Farchione A; Remington M; Winter C; Corey L
    Am J Med; 1988 Aug; 85(2A):20-5. PubMed ID: 3044086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inosine pranobex for mucocutaneous herpes.
    Mindel A
    Lancet; 1985 Mar; 1(8429):631-2. PubMed ID: 2579303
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term acyclovir suppression of frequently recurring genital herpes simplex virus infection. A multicenter double-blind trial.
    Mertz GJ; Jones CC; Mills J; Fife KH; Lemon SM; Stapleton JT; Hill EL; Davis LG
    JAMA; 1988 Jul; 260(2):201-6. PubMed ID: 3290517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous acyclovir therapy of first episodes of genital herpes: a multicenter double-blind, placebo-controlled trial.
    Peacock JE; Kaplowitz LG; Sparling PF; Durack DT; Gnann JW; Whitley RJ; Lovett M; Bryson YJ; Klein RJ; Friedman-Kien AE
    Am J Med; 1988 Sep; 85(3):301-6. PubMed ID: 3046350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inosine pranobex and mucocutaneous herpes.
    Lancet; 1985 Jan; 1(8422):200-1. PubMed ID: 2578592
    [No Abstract]   [Full Text] [Related]  

  • 13. One-year suppression of frequent recurrences of genital herpes with oral acyclovir.
    Baker DA; Blythe JG; Kaufman R; Hale R; Portnoy J
    Obstet Gynecol; 1989 Jan; 73(1):84-7. PubMed ID: 2642329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inosine pranobex.
    Glasky AJ; Galli M; Lassus A; Salo O
    Lancet; 1985 May; 1(8437):1103-4. PubMed ID: 2582218
    [No Abstract]   [Full Text] [Related]  

  • 15. Oral acyclovir suppression of recurrent genital herpes: a double-blind, placebo-controlled, crossover study.
    Halsos AM; Salo OP; Lassus A; Tjøtta EA; Hovi T; Gabrielsen BO; Fiddian AP
    Acta Derm Venereol; 1985; 65(1):59-63. PubMed ID: 2578707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged continuous versus intermittent oral acyclovir treatment in normal adults with frequently recurring genital herpes simplex virus infection.
    Mertz GJ; Eron L; Kaufman R; Goldberg L; Raab B; Conant M; Mills J; Kurtz T; Davis LG
    Am J Med; 1988 Aug; 85(2A):14-9. PubMed ID: 3044076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral acyclovir suppressive therapy in severe recurrent genital herpes. A double-blind, placebo-controlled cross-over study.
    Kroon S; Petersen CS; Andersen LP; Rasmussen LP; Vestergaard BF
    Dan Med Bull; 1989 Jun; 36(3):298-300. PubMed ID: 2666040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of recurrence after treatment of first-episode genital herpes with intravenous acyclovir.
    Corey L; Mindel A; Fife KH; Sutherland S; Benedetti J; Adler MW
    Sex Transm Dis; 1985; 12(4):215-8. PubMed ID: 3001952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic oral acyclovir in recurrent genital herpes.
    Mindel A; Weller IV; Faherty A; Sutherland S; Hindley D; Fiddian AP; Adler MW
    Lancet; 1984 Jul; 2(8394):57-9. PubMed ID: 6146006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent genital herpes suppressed by oral acyclovir: a multicentre double blind trial.
    Thin RN; Jeffries DJ; Taylor PK; Ayra OP; Rodin P; Yeo J; Fiddian AP
    J Antimicrob Chemother; 1985 Aug; 16(2):219-26. PubMed ID: 3905750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.